Campbell & CO Investment Adviser LLC increased its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 173.5% during the second quarter, HoldingsChannel reports. The fund owned 48,789 shares of the health services provider’s stock after buying an additional 30,948 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Maximus were worth $3,425,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in MMS. AQR Capital Management LLC increased its holdings in Maximus by 177.2% during the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock worth $79,341,000 after purchasing an additional 750,031 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in shares of Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock worth $117,921,000 after buying an additional 494,372 shares during the period. Boston Partners bought a new position in shares of Maximus during the first quarter worth about $20,983,000. Dimensional Fund Advisors LP raised its position in Maximus by 20.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock valued at $115,620,000 after buying an additional 288,990 shares during the last quarter. Finally, Nuveen LLC bought a new stake in Maximus in the 1st quarter valued at approximately $18,586,000. 97.21% of the stock is owned by institutional investors.
Insider Activity at Maximus
In other news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on MMS
Maximus Stock Performance
Shares of MMS opened at $84.02 on Monday. The company has a market cap of $4.73 billion, a PE ratio of 15.47 and a beta of 0.57. The firm has a 50-day moving average of $87.40 and a 200-day moving average of $78.69. Maximus, Inc. has a one year low of $63.77 and a one year high of $92.63. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27.
Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the business posted $1.74 EPS. Maximus’s revenue was up 2.5% on a year-over-year basis. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio (DPR) is presently 22.10%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- The Risks of Owning Bonds
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- How to Profit From Value Investing
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Stock Average Calculator
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
